An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
- 31 December 1991
- Vol. 12, S37-S42
- https://doi.org/10.1016/8756-3282(91)90066-r
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Is chemotherapy for metastatic non-small cell lung cancer "worth it"?Journal of Clinical Oncology, 1990
- Expensive health care. A solvable problem?Archives of internal medicine (1960), 1990
- Nonoperative management of femoral, humeral, and acetabular metastases in patients with breast carcinomaCancer, 1980
- Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patientsCancer, 1978